Poster zum Thema "Immunohematology"

Zurück
  • PS-4-11
Molecular testing for Rhesus D antigen (RhD) in patients with ambiguous results in serological testing for RhD: implications for transfusion strategy
  • PD Dr. David Juhl (Lübeck/ DE)
  • PS-4-12
Development of multiplex TaqMan probe PCR Assays for typing of up to 6 genetic markers per reaction
  • PS-4-13
Molecular blood typing of patients with Sickle Cell disease in Germany
  • PS-4-14
Compound heterozygosity for five different CD36 mutations induces CD36 type I deficiency in three members of a family of Arabian origin
  • PS-4-15
A p.Leu319Pro missense mutation in ABO likely results in a non-deletional O allele
  • PS-4-16
Routine testing for RHD*01W.1, RHD*01W.2 and RHD*01W.3 subtype alleles is dispensable in Switzerland
  • PS-4-17
Characterization of two novel ABO splice site variations preventing blood group A and B expression
  • PS-4-18
First report of the rare RhCE-depleted D--phenotype in sixteen people of Iranian origin
  • PS-4-19
The first comprehensive study of H-deficient phenotypes in Iran
  • PS-4-20
First report of known rare rhnull phenotype individuals in Iran
  • PS-4-21
Maternal red blood cell alloantibodies identified in blood samples obtained from Iranian pregnant women: the first population study in Iran
  • PS-4-22
Red blood cell immunization and contributing factors in 685 Thalassemia patients
  • PS-4-23
Titer progression of two blood group alloantibodies under massive antibody-reducing chemo- and apheresis therapy
  • PS-4-24
Experience with a triple exon RHD-NIPT and detection of maternal and fetal RH variants
  • PS-4-25
Transmission of anti-CD38 (Daratumumab) by autologous stem cell transplantation causes interference in immunohematological diagnostic
  • PS-4-26
ABO splice-site variants encoding weak A and B phenotypes complicate pre-transfusion ABO blood group diagnostics
  • PS-4-27
The strong potential of the weakly positive DAT for alloantibody elution
  • PS-4-28
Neutralization of Anti-CD38 in patient samples by a soluble CD38 protein to allow alloantibody detection procedures
  • PS-4-29
Case report: Anti-U caused mild haemolytic disease of the newborn
  • PS-4-30
Management of delivery of a woman with antibodies against high-prevalence red blood cell antigen Lan (Langereis) and von Willebrand disease
  • PS-4-31
Advantages of targeted antenatal anti-D prophylaxis in RHD negative pregnant women
  • PS-4-32
Monocytes subsets are responsible for anti-HPA-1a mediated platelet phagocytosis in blood
  • PS-4-33
Soluble CD177: A new allele for an old antigen
  • PS-4-34
Neonatal platelets loaded with anti-HPA-5b but no fetal/neonatal alloimmune thrombocytopenia (FNAIT): a case report
  • PS-4-35
Fetal and neonatal alloimmune thrombocytopenia: no evidence of systemic inflammation as a modulator of disease severity, but placental inflammation could be key
  • PS-4-36
Alpha-Methyldopa-induced autoimmune hemolytic anemia diagnosed after delivery
  • PS-4-37
World Human Neutrophil Antigens (HNAs) Investigation Survey (WHIS)
  • PS-4-38
Noninvasive fetal genotyping of red blood or platelet antigens using next generation sequencing – Experience of the last 8 years
  • PS-4-39
Passenger lymphocyte syndrome – A rare cause of immunohematological problems and hemolysis after transplantation
  • PS-4-40
Case report of resolving a KEL1 genotype-phenotype discrepancy with full-gene haplotype sequencing by Oxford Nanopore Technologies
  • PS-4-41
Case report of a rare JMH negative patient and detailed characterization with serological and molecular methods
  • PS-4-42
Significant Neutropenia induced by Metamizole-dependent neutrophil antibodies
    • v1.20.0
    • © Conventus Congressmanagement & Marketing GmbH